Clinical Trials
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase...
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with...
Clinical Trials
Grifols begins clinical trial of a new treatment that...
Grifols, a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing people’s...
Clinical Trials
Intravacc announces completion of formulation and manufacturing process development...
Intravacc, a world leader in translational research and development of vaccines, announced that a candidate polyvalent inactivated coxsackievirus B (CVB) vaccine it developed and manufactured...
Clinical Trials
Dr. Reddy’s receives approval to conduct Phase 3 clinical...
Dr. Reddy’s Laboratories Ltd announced that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for...
Clinical Trials
NeuroRx, Relief, and Quantum Leap announce the inclusion of...
NeuroRx, Inc. and RELIEF THERAPEUTICS Holding AG, and the Quantum Leap Healthcare Collaborative of San Francisco announce that NeuroRx and QLHC have signed a Clinical...
Clinical Trials
CureVac’s COVID-19 Vaccine Demonstrated Efficient Protection of Non-Human Primates...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical data...
Clinical Trials
Dr Reddy’s Laboratories gets approval for phase 3 trials...
Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.